Population-based Research to Optimize the Screening Process (PROSPR) Initiative: Research Activities and Data Sharing Webinar

September 20, 2022
1:00 – 2:30 pm EST

Watch WebinarExternal Web Site Policy

View/Download Presentation (PDF, 1.8 MB)

Background

PROSPR, or Population-based Research to Optimize the Screening Process, is an NCI-funded research network whose goal is to better understand how to improve the cervical, colorectal, and lung cancer screening processes (recruitment, screening, diagnosis, referral for treatment) in community healthcare settings in the United States. This webinar provides an overview of on-going PROSPR research as well as PROSPR DataShare (PDS), a web-based system that facilitates data sharing between PROSPR grantees and non-PROSPR researchers. Non-PROSPR researchers can use PDS to access PROSPR public use data sets and apply for custom subsets of PROSPR data. Webinar attendees will gain knowledge of specific PROSPR research projects, types of PROSPR data that can be requested, and the data request process.

Presenters

Pamela Marcus, PhD, MS, ELS
Senior Scientist and Program Director
Healthcare Assessment Research Branch
marcusp@mail.nih.gov

Pamela Marcus is a Senior Scientist and Program Director in the Healthcare Delivery Research Program's (HDRP) Healthcare Assessment Research Branch (HARB). She is an expert in assessment of cancer screening modalities in both experimental and community settings, and is author of Assessment of Cancer Screening: A Primer, an open-access publication. Dr. Marcus is the NCI Project Scientist for data harmonization, submission, and sharing in the second round of the PROSPR Initiative.

Paul Doria-Rose, PhD
Branch Chief
Healthcare Assessment Research Branch
doriarop@mail.nih.gov

Paul Doria-Rose is the Chief of the Healthcare Assessment Research Branch at the National Cancer Institute (NCI). In this role, he coordinates large research initiatives focused on cancer care delivery in community settings, including PROSPR. He also oversees the development of data resources to support economic and health services research across the cancer continuum. His personal research is focused on the evaluation of cancer screening efficacy and interval, including methods development, with a focus on colorectal and lung cancers.

Last Updated: 29 Sep, 2022